N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data.
about
Interventions for preventing neuropathy caused by cisplatin and related compoundsInterventions for preventing neuropathy caused by cisplatin and related compoundsHepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative ActivitiesOxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-AcetylcysteineChemotherapy-induced peripheral neurotoxicity: a critical analysisMitotoxicity in distal symmetrical sensory peripheral neuropathiesLifestyle-Related Factors in the Self-Management of Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer: A Systematic Review.North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled studyPathophysiology of Chemotherapy-Induced Peripheral Neuropathy.New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy.Systematic review: generating evidence-based guidelines on the concurrent use of dietary antioxidants and chemotherapy or radiotherapySelf-management of oxaliplatin-related peripheral neuropathy in colorectal cancer survivorsBase excision repair of reactive oxygen species-initiated 7,8-dihydro-8-oxo-2'-deoxyguanosine inhibits the cytotoxicity of platinum anticancer drugs.National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons.Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN).Oral administration of the amino acids cystine and theanine attenuates the adverse events of S-1 adjuvant chemotherapy in gastrointestinal cancer patients.Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy.Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats.Chemotherapy-induced peripheral neuropathy: prevention and treatment.Occupational exposure to municipal solid wastes and development of toxic neuropathies: possible role of nutrient supplementation, complementary and alternative medicines in chemoprevention.Efficacy and Interaction of Antioxidant Supplements as Adjuvant Therapy in Cancer Treatment: A Systematic Review.Chemotherapy-induced peripheral neuropathy: limitations in current prophylactic strategies and directions for future research.Potentiation of chemotherapeutics by bromelain and N-acetylcysteine: sequential and combination therapy of gastrointestinal cancer cells.Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: significance of combination therapy.Oxaliplatin-induced neuropathy in colorectal cancerChemotherapy-induced peripheral neuropathy. Part II. Prevention.Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity.The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen.Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy.In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials.Unraveling the in vitro antitumor activity of Vismia baccifera against HepG2: role of hydrogen peroxide.
P2860
Q24197763-A557A9E6-53C4-4AD5-9909-E2B0D83747FAQ24236661-9FD56382-FC3A-4047-87CF-F0CECCB5FD87Q26752622-66387D5C-BB23-4FF2-81CE-E955B068C417Q26773384-74CAC973-9ABE-4A60-9241-3CC2F02B7DD8Q27010318-CC9F1216-0139-4062-B891-3EBCF921D528Q28834071-C504C36A-9DBD-4C4A-857F-4AE65F46ED75Q30234847-184076D2-97F0-4463-8188-F6DB6B136246Q33717608-A7B1B0C1-3D5A-4676-B4E5-3F86337E1476Q33744706-ABDFB9B4-3886-4344-B1D7-B009BF7A9EE7Q36226275-E94032B4-B655-4C7B-AF1A-15D14666D127Q36883705-2EFDCA5C-2645-4325-BC1F-A11838CA7BB3Q37155944-8889FF1E-299C-4E67-B5DF-D67B624C6061Q37263083-42BCDADD-4156-4C88-9B71-C561BEF74E59Q37364316-A25A4133-7201-43E5-B864-E0E0D226CBBAQ37399781-E649D9E9-8DFF-4F1F-8A71-5A71FFA3226FQ37443089-038E42CF-F89A-4822-9DF2-953C7F836BE9Q37541146-C95883DA-9971-4337-AB4E-611D1D6192E9Q37641278-F33B704C-7322-448A-B1C1-25116EF63ABDQ37911252-8ECFDA1C-F9FD-4986-8FB6-DCE09C90137FQ38217325-45BCBAE6-41EB-4969-9AAE-FD45C63C3466Q38616751-0F7EF8D6-6209-42F0-9378-A90D6572234FQ38769139-ADD84055-2033-4C34-B744-C6C8666CCA53Q38866435-A3939304-D2D2-460E-BD17-7C4B2E75C72CQ38937722-77EF4D5B-064A-4AA1-953C-29BEBC3E1839Q39803653-E15B06A0-C6AD-4CE6-8574-B1315022D2B2Q43121191-2472DB58-0505-459A-8EFE-F383F13D6CB9Q46354075-539AA18F-5DC2-42F5-A456-5ACA1A33B4E1Q47326759-2A959716-E0D7-4CED-874E-57488A7D6F3EQ47552411-923C0F3A-644C-40FA-9B9A-C741CC9423E7Q55241487-40A72258-D98C-4C3E-8E13-6EF91C043320Q55564504-CC084D33-725A-4166-B714-050EA6A10998
P2860
N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
N-acetylcysteine has neuroprot ...... er patients: preliminary data.
@ast
N-acetylcysteine has neuroprot ...... er patients: preliminary data.
@en
type
label
N-acetylcysteine has neuroprot ...... er patients: preliminary data.
@ast
N-acetylcysteine has neuroprot ...... er patients: preliminary data.
@en
prefLabel
N-acetylcysteine has neuroprot ...... er patients: preliminary data.
@ast
N-acetylcysteine has neuroprot ...... er patients: preliminary data.
@en
P2093
P1476
N-acetylcysteine has neuroprot ...... er patients: preliminary data.
@en
P2093
Chueh-Chuan Yen
Kon-Ping Lin
Liang-Tsai Hsiao
Ming-Yang Lee
Muh-Hwa Yang
Peng-Chan Lin
Po-Min Chen
Ta-Chung Chao
Tzeon-Jye Chiou
Wei-Shu Wang
P2888
P304
P356
10.1007/S00520-006-0018-9
P577
2006-02-01T00:00:00Z
P6179
1012553615